Recently growth has led Amgen to expand in the San Francisco area in 2006. Amgen Fremont is dedicated to the manufacture of monoclonal antibody therapies, particularly Panitumumab, a novel anti-cancer medicine currently in development.

The 100,000 square-foot manufacturing facility at Fremont has strengthened Amgen's presence as an employee in the San Francisco area and will help Amgen deliver its vital medicines to "every patient, every time."